Recurrent Grade 1 Follicular Lymphoma
Showing 26 - 50 of 93
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Stanford (biological, drug, radiation)
Completed
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +6 more
- Ipilimumab
- +2 more
-
Stanford, CaliforniaStanford University Hospitals and Clinics
Nov 17, 2019
Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +99 more
- fludarabine phosphate
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 30, 2019
Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Previously Treated Myelodysplastic Syndrome, Refractory Chronic
Completed
- Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
- +115 more
- Fludarabine Phosphate
- +6 more
-
Denver, Colorado
- +10 more
Oct 29, 2019
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +77 more
- fludarabine phosphate
- +8 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Sep 16, 2019
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +44 more
- fludarabine phosphate
- +9 more
-
Duarte, California
- +6 more
Sep 6, 2019
Hematopoietic/Lymphoid Cancer, Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia Trial
Completed
- Hematopoietic/Lymphoid Cancer
- +22 more
- CART-19
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Jun 21, 2019
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Nodal Marginal Zone Lymphoma, Recurrent Grade 1
Completed
- Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
- +8 more
- Bortezomib
- +5 more
-
Scottsdale, Arizona
- +1 more
Apr 4, 2019
Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid
Completed
- Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
- +33 more
- therapeutic allogeneic lymphocytes
-
Stanford, CaliforniaStanford University
Mar 16, 2019
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Terminated
- Accelerated Phase Chronic Myelogenous Leukemia
- +110 more
- rituximab
- +12 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Feb 6, 2019
Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in
Completed
- Recurrent Adult Diffuse Large Cell Lymphoma
- +7 more
- everolimus
- bendamustine hydrochloride
-
Sacramento, CaliforniaUniversity of California Davis
Jan 2, 2019
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Rochester (rituximab, yttrium Y 90
Terminated
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +8 more
- rituximab
- +4 more
-
Rochester, MinnesotaMayo Clinic
Jul 9, 2018
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +117 more
- vorinostat
- +5 more
-
Ann Arbor, MichiganUniversity of Michigan University Hospital
Jun 28, 2018
B-cell Adult Acute Lymphoblastic Leukemia, B-cell Chronic Lymphocytic Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma Trial in
Terminated
- B-cell Adult Acute Lymphoblastic Leukemia
- +26 more
- 6,8-bis(benzylthio)octanoic acid
- +3 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jun 29, 2018
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma Trial in Atlanta, Columbus (drug, biological, other)
Terminated
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +10 more
- alisertib
- +2 more
-
Atlanta, Georgia
- +1 more
May 3, 2018
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Nodal Marginal Zone Lymphoma, Recurrent Grade 1
Completed
- Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
- +6 more
- Laboratory Biomarker Analysis
- Vorinostat
-
Duarte, California
- +4 more
Feb 5, 2018
Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3
Completed
- Contiguous Stage II Grade 1 Follicular Lymphoma
- +32 more
- pegfilgrastim
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Sep 8, 2017
Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid
Completed
- Adult Acute Myeloid Leukemia in Remission
- +41 more
- Laboratory Biomarker Analysis
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 22, 2017
Anaplastic Large Cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Seattle (drug, radiation, procedure)
Completed
- Anaplastic Large Cell Lymphoma
- +16 more
- cyclophosphamide
- +4 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Jul 21, 2017
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +30 more
- gemcitabine hydrochloride
- +3 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
May 28, 2017
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Terminated
- Accelerated Phase Chronic Myelogenous Leukemia
- +82 more
- plerixafor
- +3 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Jun 26, 2017
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +36 more
- vorinostat
- +7 more
-
Seattle, WashingtonPuget Sound Oncology Consortium
Apr 17, 2017
Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Marginal
Completed
- Contiguous Stage II Grade 1 Follicular Lymphoma
- +22 more
- pharmacological study
- +3 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Apr 14, 2017
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +67 more
- cyclophosphamide
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
May 17, 2017
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +96 more
- cyclophosphamide
- +10 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Apr 10, 2017
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Terminated
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +33 more
- Ipilimumab
- Radiation therapy
-
Stanford, CaliforniaStanford University
Jan 12, 2017